CervoMed Inc (CRVO)
19.92
-1.48
(-6.92%)
USD |
NASDAQ |
Jun 21, 16:00
19.70
-0.22
(-1.10%)
After-Hours: 20:00
CervoMed Enterprise Value: 158.04M for June 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 21, 2024 | 158.04M |
| June 20, 2024 | 170.26M |
| June 18, 2024 | 154.00M |
| June 17, 2024 | 147.56M |
| June 14, 2024 | 150.53M |
| June 13, 2024 | 156.72M |
| June 12, 2024 | 151.61M |
| June 11, 2024 | 157.14M |
| June 10, 2024 | 155.73M |
| June 07, 2024 | 152.02M |
| June 06, 2024 | 152.60M |
| June 05, 2024 | 156.06M |
| June 04, 2024 | 150.70M |
| June 03, 2024 | 155.90M |
| May 31, 2024 | 149.96M |
| May 30, 2024 | 156.15M |
| May 29, 2024 | 156.81M |
| May 28, 2024 | 144.01M |
| May 24, 2024 | 147.89M |
| May 23, 2024 | 149.87M |
| May 22, 2024 | 150.53M |
| May 21, 2024 | 154.08M |
| May 20, 2024 | 156.56M |
| May 17, 2024 | 192.46M |
| May 16, 2024 | 194.69M |
| Date | Value |
|---|---|
| May 15, 2024 | 197.66M |
| May 14, 2024 | 197.50M |
| May 13, 2024 | 195.43M |
| May 10, 2024 | 197.17M |
| May 09, 2024 | 190.89M |
| May 08, 2024 | 194.94M |
| May 07, 2024 | 195.02M |
| May 06, 2024 | 194.44M |
| May 03, 2024 | 192.21M |
| May 02, 2024 | 192.88M |
| May 01, 2024 | 193.12M |
| April 30, 2024 | 194.11M |
| April 29, 2024 | 197.74M |
| April 26, 2024 | 140.61M |
| April 25, 2024 | 147.83M |
| April 24, 2024 | 145.43M |
| April 23, 2024 | 143.51M |
| April 22, 2024 | 141.04M |
| April 19, 2024 | 141.72M |
| April 18, 2024 | 149.44M |
| April 17, 2024 | 147.89M |
| April 16, 2024 | 146.97M |
| April 15, 2024 | 137.71M |
| April 12, 2024 | 149.07M |
| April 11, 2024 | 149.13M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-21.01M
Minimum
Apr 28 2022
197.74M
Maximum
Apr 29 2024
21.55M
Average
9.037M
Median
Enterprise Value Benchmarks
| GlucoTrack Inc | 10.86M |
| AIM ImmunoTech Inc | 13.37M |
| Perspective Therapeutics Inc | 501.28M |
| Protalix BioTherapeutics Inc | 57.71M |
| Armata Pharmaceuticals Inc | 200.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.514M |
| Total Expenses (Quarterly) | 2.595M |
| EPS Diluted (Quarterly) | -0.41 |
| Earnings Yield | -15.49% |